- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Granulomatosis with polyangiitis and microscopic polyangiitis
- Meeting Date: March 2024
- Public Summary Document (PSD) March 2024 PBAC Meeting - (PDF 1.1MB)
- Public Summary Document (PSD) March 2024 PBAC Meeting - (Word 477KB)
Avacopan – March 2024
Avacopan: Capsule 10 mg; Tavneos®
Last updated
30 May 2025